Discovered Only When a Bypass Is Needed: In One of Every Five Limbs with Varicose Veins, the Great Saphenous Vein Has Already Been Ablated
    GCM team August 12, 2026 No Comments

    Key Takeaways In 2024, a team at Pirogov Russian National Research Medical University in

    READ MORE
    Treat the Tributaries First, Leave the Trunk Alone: Nearly Three-Quarters of Patients Needed No Further Treatment Within a Year
    GCM team August 1, 2026 No Comments

    Key Takeaways The SAPTAP trial, published in the British Journal of Surgery in 2023,

    READ MORE
    In the Five Trials Underpinning the Cochrane Conclusion, More Than 200 Patients in the “CHIVA Arms” Received Treatment That Did Not Follow CHIVA Principles
    GCM team July 27, 2026 No Comments

    Key Takeaways In 2023, Massimo Cappelli, Raffaele Molino Lova, Mauro Pinelli, and Claude Franceschi

    READ MORE
    Bringing the Vein Closer to the Skin with Ultrasound: A Technical Refinement That Makes CHIVA Incisions Smaller for Obese Patients
    GCM team July 20, 2026 No Comments

    Key Takeaways • Study basis: In 2024, Faccini and Grill of Brazil published a

    READ MORE
    An Independent Network Meta-Analysis of 75 Studies: CHIVA’s Recurrence Rate Is Significantly Lower Than Radiofrequency Ablation’s
    GCM team July 17, 2026 No Comments

    Key Takeaways • Study basis: In 2024, a team at King Abdulaziz University in

    READ MORE
    A Direct Comparison with Mainstream Radiofrequency Ablation: Similar Outcomes with CHIVA, and a Shorter Hospital Stay
    GCM team July 10, 2026 No Comments

    Key Takeaways • Study basis: In 2023, Lee et al. published a retrospective, propensity-score-matched

    READ MORE
    Both Normalize Reflux Parameters, Yet Destroying the Vein May Leave a Problem Preservation Does Not
    GCM team July 8, 2026 No Comments

    Key Takeaways • Study basis: In 2023, Cappelli, Molino Lova, Pinelli, and Franceschi published

    READ MORE
    A Preoperative Flow Signal May Indicate That Some Type III Shunt Patients Can Remain Stable After a Single Step
    GCM team July 2, 2026 No Comments

    Key Takeaways • Study basis: In 2024, Cappelli, Molino Lova, Pinelli, and Franceschi published

    READ MORE
    When Cleveland Clinic Maps the Venous-Treatment Landscape, CHIVA Appears Among the “Preserve the Saphenous Vein” Options
    GCM team June 30, 2026 No Comments

    Key Takeaways • Study basis: In 2025, a vascular surgery team at the Cleveland

    READ MORE
    In a Network Meta-Analysis Spanning Multiple Procedures, CHIVA Ranks Among the Highest for Long-Term Efficacy
    GCM team June 25, 2026 No Comments

    Key Takeaways • Study basis: In 2019, Guo et al. published a network meta-analysis

    READ MORE
    Page1 Page2 Page3 Page4
    Recent Post

    DR. SMILE MEDICAL GROUP Granted HMO NPI – Paving the Way for Medical Network Expansion

    June 9, 2025

    Global CHIVA Management (GCM) Registered as Official Trade Name in New York State

    June 9, 2025

    Dr. Qiang Zhang Meets Vascular Care Group: Accelerating CHIVA Adoption in North America and Building Global Collaboration

    June 26, 2025
    Gallery

    Stay Connected with GCM

    Subscribe to our newsletter for updates on CHIVA insights, training, and global developments.

    CALL US

    COMING SOON

    EMAIL US

    contact@globalchiva.com

    ADDRESS

    36 East 36th Street New York, NY 10016

    © 2025 DR.SMILE MEDICAL GROUP, INC. All rights reserved..Global CHIVA Management iS a DBA Of DR.SMILE MEDICAL GROUP, INC